As of August 28, 2026, TScan Therapeutics, Inc. (TCRX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. TScan Therapeutics, Inc. has a market capitalization of $70.58M, 23.98M shares outstanding, 62 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.11 approaching $1 threshold
Market Data
Market Cap$70.58M
Shares Outstanding23.98M
FloatN/A
Cash$115.10M
Debt$32.78M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 16.5% shares (2026Q1 vs prior)
62 institutional holders · 36.15M shares
#1
Lynx1 Capital Management LP
8.02M shares
#2
BVF INC/IL
5.56M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
4.31M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest1.56M
Days to Cover2.8
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2024-12-31
4
INSIDER TRANSACTION
2026-01-22
4
INSIDER TRANSACTION
2026-01-22
4
INSIDER TRANSACTION
2026-01-22
4
INSIDER TRANSACTION
2026-01-22
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual TCRX Dilution Snapshot
TScan Therapeutics, Inc. (TCRX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for TCRX: 4 on 2026-01-22; 4 on 2026-01-22; 4 on 2026-01-22.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track TCRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TCRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for TCRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.